Prognostic and clinicopathological significance of systemic inflammation response index in patients with hepatocellular carcinoma: a systematic review and meta …
S Zhang, Z Tang - Frontiers in Immunology, 2024 - frontiersin.org
Background It is unclear whether the systemic inflammation response index (SIRI) can
predict the prognosis of patients with hepatocellular carcinoma (HCC). Consequently, the …
predict the prognosis of patients with hepatocellular carcinoma (HCC). Consequently, the …
[HTML][HTML] Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
L Xu, S Yu, L Zhuang, P Wang, Y Shen, J Lin, Z Meng - Oncotarget, 2017 - ncbi.nlm.nih.gov
The systemic inflammation response index (SIRI) is a useful tool for predicting prognosis in
some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in …
some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in …
Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: a meta-analysis
B Wang, Y Huang, T Lin - Medicine, 2020 - journals.lww.com
Background: There is a growing literature on the significance of systemic immune-
inflammation index in hepatocellular carcinoma. However, the results were inconsistent due …
inflammation index in hepatocellular carcinoma. However, the results were inconsistent due …
Systemic immune-inflammation index in hepatocellular carcinoma patients survival outcomes: a meta-analysis
L Yanan, Q Jing, L Weiwei - 2021 - ir.lzu.edu.cn
摘要 Objective: A meta-analysis was conducted to estimate the prognostic value of systemic
immune-inflammation index (SII) for the patients with HCC. Methods: The databases …
immune-inflammation index (SII) for the patients with HCC. Methods: The databases …
Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index
M Zhao, X Duan, L Mi, J Shi, N Li, X Yin, X Han… - Future …, 2022 - Taylor & Francis
Aim: To explore the prognostic value of the systemic inflammatory response index (SIRI) and
peripheral blood T-cell subsets in patients with hepatocellular carcinoma (HCC) and the …
peripheral blood T-cell subsets in patients with hepatocellular carcinoma (HCC) and the …
Clinical significance of systemic inflammation markers in newly diagnosed, previously untreated hepatocellular carcinoma
JI Yu, HC Park, GS Yoo, SW Paik, MS Choi, HS Kim… - Cancers, 2020 - mdpi.com
This study aimed to investigate the clinical significance of systemic inflammation markers
(SIMs)—including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) …
(SIMs)—including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) …
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
B Hu, XR Yang, Y Xu, YF Sun, C Sun, W Guo… - Clinical Cancer …, 2014 - AACR
Purpose: We developed a novel systemic immune-inflammation index (SII) based on
lymphocyte, neutrophil, and platelet counts and explored its prognostic value in …
lymphocyte, neutrophil, and platelet counts and explored its prognostic value in …
Systemic inflammation response index is a prognostic risk factor in patients with hepatocellular carcinoma undergoing TACE
TC Wang, TZ An, JX Li, PF Pang - Risk Management and …, 2021 - Taylor & Francis
Background Mounting evidence has shown that systemic inflammation response index
(SIRI), a novel prognostic biomarker based on peripheral lymphocyte, neutrophil and …
(SIRI), a novel prognostic biomarker based on peripheral lymphocyte, neutrophil and …
A systemic inflammation response score for prognostic prediction in hepatocellular carcinoma patients after hepatectomy
D Zhang, L Huo, Y Pan, Z Yang, H Zeng… - Journal of …, 2022 - Taylor & Francis
Purpose To investigate the value of preoperative systemic inflammation response (SIRS)
score in predicting the prognosis of hepatocellular carcinoma (HCC) after hepatectomy …
score in predicting the prognosis of hepatocellular carcinoma (HCC) after hepatectomy …
[HTML][HTML] Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients after liver transplantation for hepatocellular carcinoma within …
H Fu, J Zheng, J Cai, K Zeng, J Yao, L Chen… - Cellular Physiology and …, 2018 - karger.com
Background: There is growing evidence that the systemic immune-inflammation index (SII),
a novel prognostic biomarker based on peripheral lymphocyte, neutrophil, and platelet …
a novel prognostic biomarker based on peripheral lymphocyte, neutrophil, and platelet …
相关搜索
- hepatocellular carcinoma immune inflammation
- hepatocellular carcinoma meta analysis
- meta analysis immune inflammation
- hepatocellular carcinoma response index
- hepatocellular carcinoma prognosis of patients
- immune cells response index
- meta analysis prognostic impact
- prognosis of patients immune inflammation
- hepatocellular carcinoma clinical significance
- carcinoma patients survival outcomes
- meta analysis survival outcomes
- hepatocellular carcinoma hangzhou criteria
- hepatocellular carcinoma curative resection
- hepatocellular carcinoma liver transplantation
- hepatocellular carcinoma risk factor
- meta analysis human malignancy